RH

Robert Healey

Sr Scientist II at Heptares Therapeutics

Robert Healey's work experience includes:

1. Sr Scientist II at Sosei Heptares (2021-present): Currently holding this role.

2. Sr Scientist I at Sosei Heptares (2021-2023): Previous role before being promoted to Sr Scientist II.

3. Postdoctoral Research Associate at IGF, University of Montpellier, CNRS, INSERM (2017-2021): Conducted research on structural and functional characterization of integral membrane proteins involved in sphingolipid metabolism. Managed multiple projects and supervised a team.

4. PhD Candidate at UNSW (2013-2017): Researched the activation mechanisms of GPCRs by protein agonists. Established collaborations between different faculties and an industry partner. Also served as a Laboratory Demonstrator for undergraduate and masters students, teaching various scientific concepts and lab skills.

5. Analytical Chemist at Neptune Bio-Innovations Pty Ltd (2013-2017): Developed analytical methods for product testing and contributed to product development as part of a multidisciplinary team.

6. Laboratory Demonstrator at University of Canberra (2012): Worked as a laboratory demonstrator.

7. Researcher exchange at Kyoto Institute of Technology (2012): Conducted HPLC/nanoLC and synthesis of functionalized stationary phases for the separation of chiral pharmaceuticals during a three-month research exchange.

These experiences showcase Robert Healey's expertise in protein science, structural biology, crystallography, molecular biology, biotechnology, and analytical chemistry. Robert has also demonstrated leadership, collaboration, teaching, and project management skills throughout their career.

Robert Healey's education history begins with their completion of a High School Certificate at North Sydney Boys High School from 2002 to 2007. Following this, they attended the University of Canberra from 2009 to 2012, where they obtained a Bachelor of Applied Science (Honours) in Analytical Chemistry. Finally, they pursued further studies at UNSW from 2013 to 2017, earning a Doctor of Philosophy (PhD) in Chemistry with a focus on Chemical Biology.

Location

Cambridge, United Kingdom

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Heptares Therapeutics

Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.